BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of (225)Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular Carcinoma
BANTAM-01：一项多中心、开放标签、首次人体I期剂量递增和扩展研究，旨在评估(225)Ac-GPC3 (BAY 3547926)在晚期肝细胞癌患者中的疗效
期刊:
影响因子:
doi:10.2967/jnumed.125.270814
Tjeertes, Jorrit; Dostalek, Miroslav; Glaus, Charles; Gupta, Vinita; Li, Daneng; Nestler, Antje; Pelekanou, Vasiliki; Pinkert, Joerg; Ratih, Ida; Smith, Eric; Subramanyam, Shyamal; Vogel, Arndt; Walker, Katrina; Wilson Woods, Andrea; Zimmermann, Stefan; Junger, Henrik
